SCM Biotech

SCM BIOTECHNOLOGY Co. is an innovative biotechnology company that was established in 2021 as part of a university-industry cooperation initiative at the Technopark in Turkey. The company's main objective is to create R&D-based biotechnology and biomedical research outputs while adhering to high technology standards. SCM BIOTECHNOLOGY focuses on the production of Nucleic Acid Isolation Kits, ELISA Kits, and Fragment and Sequence Analysis Kits at its R&D center located in Technopark. Notably, the company has three R&D projects supported by the Ministry of Industry, with one project receiving support from TUBITAK SME R&D Start-Up Support Program (1507) for the diagnosis and follow-up of SMA disease. In addition, SCM BIOTECHNOLOGY actively engages in cooperation processes with the Ministry of Industry and TUBITAK institutions for its R&D projects while maintaining a strong focus on social responsibility. The company has defined its mission to bring creative discoveries and innovative research strategies to life, with a focus on maintaining and improving health. Furthermore, it aims to contribute to the development, protection, and renewal of scientific and physical resources to prevent diseases, expand the knowledge base in medicine and related sciences, and promote the highest level of scientific integration, public accountability, and social responsibility in the conduct of science. Overall, SCM BIOTECHNOLOGY is positioned as a promising player in the biotechnology industry, leveraging its strong R&D focus and collaboration with governmental institutions to drive innovation and societal impact.